CLINICAL_TRIALS trial_result · 2014-08-26

Clinical Trial Update: A Study of Management of Tarceva - Induced Rash in Patients With Non-Small Cell Lung Cancer. [Phase 2]

A Phase 2 study evaluating management of Tarceva-induced rash in patients with non-small cell lung cancer has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Hoffmann-La Roche | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-08-26